IP Verse

Methods And Compositions For The Targeted Modification Of A Genome - EP3080279

PATENT ANALYSIS

Patent Details

Grant Date: Sep 26, 2018
Company: REGENERON PHARMACEUTICALS, INC.
Oppositions

More patents of Regeneron Pharmaceuticals, Inc.

Want to monitor this patent?

Feel free to send us a message here and we will get back to you